These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

317 related items for PubMed ID: 8911366

  • 1. Significance of serum free prostate specific antigen in the screening of prostate cancer.
    Higashihara E, Nutahara K, Kojima M, Okegawa T, Miura I, Miyata A, Kato M, Sugisaki H, Tomaru T.
    J Urol; 1996 Dec; 156(6):1964-8. PubMed ID: 8911366
    [Abstract] [Full Text] [Related]

  • 2. Prostate cancer screening within a prostate specific antigen range of 3 to 3.9 ng./ml.: a comparison of digital rectal examination and free prostate specific antigen as supplemental screening tests.
    Mäkinen T, Tammela TL, Hakama M, Stenman UH, Rannikko S, Aro J, Juusela H, Määttänen L, Auvinen A.
    J Urol; 2001 Oct; 166(4):1339-42. PubMed ID: 11547069
    [Abstract] [Full Text] [Related]

  • 3. Percent free prostate specific antigen in the total prostate specific antigen 2 to 4 ng./ml. range does not substantially increase the number of biopsies needed to detect clinically significant prostate cancer compared to the 4 to 10 ng./ml. range.
    Haese A, Dworschack RT, Partin AW.
    J Urol; 2002 Aug; 168(2):504-8. PubMed ID: 12131298
    [Abstract] [Full Text] [Related]

  • 4. Optimal predictors of prostate cancer on repeat prostate biopsy: a prospective study of 1,051 men.
    Djavan B, Zlotta A, Remzi M, Ghawidel K, Basharkhah A, Schulman CC, Marberger M.
    J Urol; 2000 Apr; 163(4):1144-8; discussion 1148-9. PubMed ID: 10737484
    [Abstract] [Full Text] [Related]

  • 5. The free-to-total prostate specific antigen ratio improves the specificity of prostate specific antigen in screening for prostate cancer in the general population.
    Bangma CH, Rietbergen JB, Kranse R, Blijenberg BG, Petterson K, Schröder FH.
    J Urol; 1997 Jun; 157(6):2191-6. PubMed ID: 9146612
    [Abstract] [Full Text] [Related]

  • 6. Comparison of percent free prostate specific antigen and prostate specific antigen density as methods to enhance prostate specific antigen specificity in early prostate cancer detection in men with normal rectal examination and prostate specific antigen between 4.1 and 10 ng./ml.
    Morote J, Raventós CX, Lorente JA, Lopez-Pacios MA, Encabo G, de Torres I, Andreu J.
    J Urol; 1997 Aug; 158(2):502-4. PubMed ID: 9224333
    [Abstract] [Full Text] [Related]

  • 7. Serial biopsy results in prostate cancer screening study.
    Roehl KA, Antenor JA, Catalona WJ.
    J Urol; 2002 Jun; 167(6):2435-9. PubMed ID: 11992052
    [Abstract] [Full Text] [Related]

  • 8. Prospective evaluation of prostate specific antigen and prostate specific antigen density in the detection of nonpalpable and stage T1C carcinoma of the prostate.
    Presti JC, Hovey R, Carroll PR, Shinohara K.
    J Urol; 1996 Nov; 156(5):1685-90. PubMed ID: 8863571
    [Abstract] [Full Text] [Related]

  • 9. Population-based screening for prostate cancer by measuring total serum prostate-specific antigen in Iran.
    Hosseini SY, Moharramzadeh M, Ghadian AR, Hooshyar H, Lashay AR, Safarinejad MR.
    Int J Urol; 2007 May; 14(5):406-11. PubMed ID: 17511722
    [Abstract] [Full Text] [Related]

  • 10. [The incidence of the variability of the free PSA/total PSA ratio on the early diagnosis of prostate cancer].
    de La Taille A, Houlgatte A, Houdelette P, Berlizot P, Fournier R, Ricordel I.
    Prog Urol; 1997 Jun; 7(3):455-63. PubMed ID: 9273075
    [Abstract] [Full Text] [Related]

  • 11. The lack of predictive value of prostate specific antigen density in the detection of prostate cancer in patients with normal rectal examinations and intermediate prostate specific antigen levels.
    Cookson MS, Floyd MK, Ball TP, Miller EK, Sarosdy MF.
    J Urol; 1995 Sep; 154(3):1070-3. PubMed ID: 7543601
    [Abstract] [Full Text] [Related]

  • 12. Effect of digital rectal examination and needle biopsy on serum total and percentage of free prostate specific antigen levels.
    Ornstein DK, Rao GS, Smith DS, Ratliff TL, Basler JW, Catalona WJ.
    J Urol; 1997 Jan; 157(1):195-8. PubMed ID: 8976249
    [Abstract] [Full Text] [Related]

  • 13. Prostate specific antigen based biennial screening is sufficient to detect almost all prostate cancers while still curable.
    Hugosson J, Aus G, Lilja H, Lodding P, Pihl CG, Pileblad E.
    J Urol; 2003 May; 169(5):1720-3. PubMed ID: 12686817
    [Abstract] [Full Text] [Related]

  • 14. Prostate-specific antigen velocity at low prostate-specific antigen levels as screening tool for prostate cancer: results of second screening round of ERSPC (ROTTERDAM).
    Roobol MJ, Kranse R, de Koning HJ, Schröder FH.
    Urology; 2004 Feb; 63(2):309-13; discussion 313-5. PubMed ID: 14972478
    [Abstract] [Full Text] [Related]

  • 15. Screening for prostate cancer at low PSA range: the impact of digital rectal examination on tumor incidence and tumor characteristics.
    Gosselaar C, Roobol MJ, Roemeling S, van der Kwast TH, Schröder FH.
    Prostate; 2007 Feb 01; 67(2):154-61. PubMed ID: 17044079
    [Abstract] [Full Text] [Related]

  • 16. [Detection of cancer of the prostate. A study of 600 cases].
    Teillac P, Bron J, Tobolski F, Cussenot O, Lesourd A, Leroy M, Toubert ME, Brocheriou C, Laval-Jeantet M, Le Duc A.
    Ann Urol (Paris); 1990 Feb 01; 24(1):37-41. PubMed ID: 1690963
    [Abstract] [Full Text] [Related]

  • 17. Comparison of different prostate-specific antigen cutpoints for early detection of prostate cancer: results of a large screening study.
    Reissigl A, Pointner J, Horninger W, Ennemoser O, Strasser H, Klocker H, Bartsch G.
    Urology; 1995 Nov 01; 46(5):662-5. PubMed ID: 7495117
    [Abstract] [Full Text] [Related]

  • 18. Prostate-specific antigen change in the European Randomized Study of Screening for Prostate Cancer, section Rotterdam.
    Raaijmakers R, Wildhagen MF, Ito K, Pàez A, de Vries SH, Roobol MJ, Schröder FH.
    Urology; 2004 Feb 01; 63(2):316-20. PubMed ID: 14972481
    [Abstract] [Full Text] [Related]

  • 19. Characteristics of prostate cancer detected by digital rectal examination only.
    Okotie OT, Roehl KA, Han M, Loeb S, Gashti SN, Catalona WJ.
    Urology; 2007 Dec 01; 70(6):1117-20. PubMed ID: 18158030
    [Abstract] [Full Text] [Related]

  • 20. Development of a new nomogram for predicting the probability of a positive initial prostate biopsy in Japanese patients with serum PSA levels less than 10 ng/mL.
    Kawamura K, Suzuki H, Kamiya N, Imamoto T, Yano M, Miura J, Shimbo M, Suzuki N, Nakatsu H, Ichikawa T.
    Int J Urol; 2008 Jul 01; 15(7):598-603. PubMed ID: 18462353
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.